MCID: FBR003
MIFTS: 43

Fibrous Histiocytoma malady

Categories: Cancer diseases

Aliases & Classifications for Fibrous Histiocytoma

Aliases & Descriptions for Fibrous Histiocytoma:

Name: Fibrous Histiocytoma 12 14
Histiocytoma, Benign Fibrous 42 69
Benign Fibrous Histiocytoma 12
Fibrous Histiocytoma Nos 12
Histiocytoma Fibrous 52
Fibroxanthoma Nos 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4415
MeSH 42 D018219
NCIt 47 C3739
UMLS 69 C0206644

Summaries for Fibrous Histiocytoma

MalaCards based summary : Fibrous Histiocytoma, also known as histiocytoma, benign fibrous, is related to osteomyelitis and desmoid tumor. An important gene associated with Fibrous Histiocytoma is ATF1 (Activating Transcription Factor 1), and among its related pathways/superpathways are TGF-beta Signaling Pathways and Striated Muscle Contraction. The drugs Doxorubicin and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and breast, and related phenotype is muscle.

Wikipedia : 71 Benign fibrous histiocytomas (also known as dermal dendrocytoma,dermatofibroma,fibrous... more...

Related Diseases for Fibrous Histiocytoma

Diseases related to Fibrous Histiocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 262)
id Related Disease Score Top Affiliating Genes
1 osteomyelitis 30.1 ACTC1 DES VIM
2 desmoid tumor 29.8 ACTC1 S100B VIM
3 cardiac tamponade 29.8 DES MYOD1
4 diaphyseal medullary stenosis with malignant fibrous histiocytoma 12.6
5 cutaneous fibrous histiocytoma 12.3
6 malignant fibrous histiocytoma of bone 12.2
7 malignant skin fibrous histiocytoma 12.1
8 benign deep fibrous histiocytoma 12.0
9 undifferentiated pleomorphic sarcoma 11.9
10 sclerosing hemangioma 11.8
11 histiocytoma, angiomatoid fibrous, somatic 11.8
12 histiocytoma 11.7
13 myxofibrosarcoma 11.3
14 malignant fibroxanthoma 11.1
15 tenosynovial giant cell tumor 11.1
16 pigmented villonodular synovitis 11.0
17 urachal cancer 11.0
18 sarcoma 10.5
19 inflammatory linear verrucous epidermal nevus 10.3 DES VIM
20 lymphomatous thyroiditis 10.3 DES VIM
21 marfanoid hypermobility syndrome 10.3 DES VIM
22 adult endodermal sinus tumor 10.3 DES VIM
23 cortical blindness 10.3 F13A1 VIM
24 tanycytic ependymoma 10.3 DES VIM
25 reticulohistiocytic granuloma 10.3 DES F13A1
26 hematologic cancer 10.3 F13A1 VIM
27 aneurysm 10.3
28 lymphomatoid papulosis 10.3 ACTC1 VIM
29 chest wall parachordoma 10.3 ACTC1 VIM
30 carbon monoxide-induced parkinsonism 10.3 ACTC1 DES
31 dystrophic epidermolysis bullosa, nails only 10.3 ACTC1 F13A1
32 liver angiosarcoma 10.2 DES VIM
33 vagina leiomyosarcoma 10.2 ACTC1 DES
34 secondary adrenal insufficiency 10.2 ACTC1 F13A1
35 liposarcoma 10.2
36 mixed type rhabdomyosarcoma 10.2 DES MYOD1
37 typical urticaria pigmentosa 10.2 F13A1 S100B
38 lupus - neurological sequelae 10.2 S100B VIM
39 verruciform xanthoma of skin 10.2 DES MYOD1
40 benign schwannoma 10.2 S100B VIM
41 ectopic pregnancy 10.2 DES MYOD1
42 testis sarcoma 10.2 DES MYOD1
43 male reproductive system disease 10.2 DES VIM
44 transitional cell carcinoma 10.2 DES MYOD1
45 jejunal neuroendocrine tumor 10.2 S100B VIM
46 hepatitis 10.2
47 microinvasive cervical squamous cell carcinoma 10.2 S100B VIM
48 bilateral multicystic dysplastic kidney 10.2 ATF1 CREB1 EWSR1
49 amelogenesis imperfecta-gingival hyperplasia syndrome 10.2 MYOD1 SERPINA3
50 13q12.3 microdeletion syndrome 10.2 ACTC1 DES VIM

Graphical network of the top 20 diseases related to Fibrous Histiocytoma:



Diseases related to Fibrous Histiocytoma

Symptoms & Phenotypes for Fibrous Histiocytoma

MGI Mouse Phenotypes related to Fibrous Histiocytoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 9.1 VIM ACTC1 CD163 CREB1 DES MYOD1

Drugs & Therapeutics for Fibrous Histiocytoma

Drugs for Fibrous Histiocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 105)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
3
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
4
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
5
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
6
Dactinomycin Approved Phase 3 50-76-0 2019 457193
7
Epirubicin Approved Phase 3 56420-45-2 41867
8
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
9
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
10
Lenograstim Approved Phase 3,Phase 2 135968-09-1
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
13 Alkylating Agents Phase 3,Phase 2,Phase 1
14 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
15 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
16 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
17 Isophosphamide mustard Phase 3,Phase 2,Phase 1
18 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
19 Anti-Infective Agents Phase 3,Phase 2,Phase 1
20 Antimitotic Agents Phase 3,Phase 2,Phase 1
21 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
22 Antirheumatic Agents Phase 3,Phase 2,Phase 1
23 Etoposide phosphate Phase 3,Phase 2
24 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
25 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
26
Indinavir Approved Phase 2 150378-17-9 5362440
27
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
28
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
29
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
30
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
31
Bevacizumab Approved, Investigational Phase 2 216974-75-3
32
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
33
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
34
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177
35
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
36
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 5284616 6436030 46835353
37
Gemcitabine Approved Phase 2,Phase 1 95058-81-4 60750
38
Paclitaxel Approved, Vet_approved Phase 1, Phase 2 33069-62-4 36314
39
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
40
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
41
Pembrolizumab Approved Phase 1, Phase 2 1374853-91-4
42
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
43
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
44
Nicotinamide Approved, Nutraceutical Phase 2 98-92-0 936
45
leucovorin Approved, Nutraceutical Phase 2 58-05-9 54575, 6560146 143
46
Camptothecin Experimental Phase 2 7689-03-4
47
Docetaxel Approved May 1996, Investigational Phase 2,Phase 1 114977-28-5 148124 9877265
48 Anti-HIV Agents Phase 2
49 Anti-Retroviral Agents Phase 2
50 Antiviral Agents Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 61)
id Name Status NCT ID Phase
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3
2 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Unknown status NCT00346164 Phase 3
3 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3
4 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3
5 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3
6 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Completed NCT00091351 Phase 3
7 Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3
8 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3
9 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3
10 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3
11 Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Recruiting NCT01344018 Phase 3
12 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
13 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3
14 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
15 Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2
16 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2
17 Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma Completed NCT00031915 Phase 2
18 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2
19 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2
20 Bevacizumab and Radiation Therapy for Sarcomas Completed NCT00356031 Phase 2
21 Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
22 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2
23 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2
24 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2
25 Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Completed NCT00085475 Phase 2
26 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2
27 Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Completed NCT00949325 Phase 1, Phase 2
28 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2
29 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2
30 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2
31 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2
32 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2
33 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2
34 Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes Completed NCT00887809 Phase 2
35 Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01154452 Phase 1, Phase 2
36 Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma Recruiting NCT01883518 Phase 1, Phase 2
37 Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Recruiting NCT02601209 Phase 1, Phase 2
38 Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Recruiting NCT02584309 Phase 2
39 Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Recruiting NCT01532687 Phase 2
40 To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Recruiting NCT01962103 Phase 1, Phase 2
41 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Active, not recruiting NCT00667342 Phase 2
42 Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Active, not recruiting NCT01653028 Phase 2
43 Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma Not yet recruiting NCT03123276 Phase 1, Phase 2
44 Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery Not yet recruiting NCT02923778 Phase 2
45 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
46 Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) Terminated NCT01418001 Phase 1, Phase 2
47 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1
48 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1
49 Vaccine Therapy in Treating Patients With Metastatic Cancer Completed NCT00020267 Phase 1
50 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1

Search NIH Clinical Center for Fibrous Histiocytoma

Cochrane evidence based reviews: histiocytoma, benign fibrous

Genetic Tests for Fibrous Histiocytoma

Anatomical Context for Fibrous Histiocytoma

MalaCards organs/tissues related to Fibrous Histiocytoma:

39
Bone, Skin, Breast, Lung, Heart, Liver, Colon

Publications for Fibrous Histiocytoma

Articles related to Fibrous Histiocytoma:

(show top 50) (show all 823)
id Title Authors Year
1
Primary malignant fibrous histiocytoma of long bones: long-term follow-up. ( 27499321 )
2016
2
Fibrous Histiocytoma of the Conjunctiva. ( 27636240 )
2016
3
Conjunctival fibrous histiocytoma in an 8-year-old boy. ( 27282913 )
2016
4
Benign Fibrous Histiocytoma: A Rare Case Report and Literature Review. ( 26929563 )
2016
5
Malignant Fibrous Histiocytoma of the Testicular Appendages Mimicking an Obstructed Hernia in an Elderly Man: Case Report and Review of the Literature. ( 26953736 )
2016
6
'Pure' spindle cell variant of angiomatoid fibrous histiocytoma, lacking classic histologic features. ( 27637157 )
2016
7
Angiomatoid fibrous histiocytoma: novel MR imaging findings. ( 26919861 )
2016
8
Malignant fibrous histiocytoma of the skin. A case treated with radiotherapy. ( 26837483 )
2016
9
Deep Penetrating Fibrous Histiocytoma: A Case Report and Implications for Surgical Management. ( 26999346 )
2016
10
Intracranial Angiomatoid Fibrous Histiocytoma: Case Report and Literature Review. ( 27667574 )
2016
11
14-Year-Old Boy With Mild Antecedent Neck Pain in Setting of Acute Trauma: A Rare Case of Benign Fibrous Histiocytoma of the Spine. ( 26991583 )
2016
12
Benign Fibrous Histiocytoma of the Frontal Bone. ( 27054431 )
2016
13
An unresectable retroperitoneal malignant fibrous histiocytoma: A case report. ( 27073487 )
2016
14
Primary malignant fibrous histiocytoma of the colon: A case report and review of the literature. ( 27284436 )
2016
15
ALK Rearrangement and Overexpression in an Unusual Cutaneous Epithelioid Tumor With a Peculiar Whorled "Perineurioma-like" Growth Pattern: Epithelioid Fibrous Histiocytoma. ( 27438515 )
2016
16
Angiomatoid fibrous histiocytoma: Clinicopathological spectrum of five cases, including EWSR1-CREB1 positive result in a single case. ( 27166030 )
2016
17
Primary malignant fibrous histiocytoma of the liver. ( 27826563 )
2016
18
Subcutaneous Benign Fibrous Histiocytoma: Rare Presentation on Cheek-Case Report and Review of Literature. ( 27408454 )
2016
19
Computed tomography and magnetic resonance imaging findings of malignant fibrous histiocytoma of the head and neck. ( 27123302 )
2016
20
Malignant fibrous histiocytoma of the skin: a case treated with radiotherapy. ( 27176091 )
2016
21
Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco-regional lymph nodes that responded to chemotherapy. ( 28012233 )
2016
22
Benign Fibrous Histiocytoma of Mandible: A Case Report and Updated Review. ( 27504429 )
2016
23
Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report. ( 26917971 )
2016
24
Primary Angiomatoid Fibrous Histiocytoma of the Lung with Mediastinal Lymph Node Metastasis. ( 27544801 )
2016
25
A case of recurrent malignant fibrous histiocytoma of the mesentery. ( 27351621 )
2016
26
Double primary malignant fibrous histiocytoma and squamous cell carcinoma of the larynx treated with laser laryngeal conservation surgery. ( 27170836 )
2016
27
Intraspinal extradural benign fibrous histiocytoma of the lumbar spine in a pediatric patient. Case report and literature review. ( 26984808 )
2016
28
Benign fibrous histiocytoma of the fronto-temporo-parietal region: a case report and review of the literature. ( 26823894 )
2015
29
A rare case of malignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma NOS) of the vocal fold. ( 26214667 )
2015
30
Unusual localization of a primary pleomorphic malignant fibrous histiocytoma on the mitral valve: a case report and review of the literature. ( 26518517 )
2015
31
ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. ( 25857825 )
2015
32
Electron microscopic observation of cholesterotic fibrous histiocytoma of the finger. ( 26011092 )
2015
33
Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing. ( 26121314 )
2015
34
Benign fibrous histiocytoma arising at the temporal bone of an infant-case report and review of the literature. ( 26174620 )
2015
35
Paraneoplastic Syndrome of Angiomatoid Fibrous Histiocytoma May Be Caused by EWSR1-CREB1 Fusion-induced Excessive Interleukin-6 Production. ( 26165403 )
2015
36
Benign fibrous histiocytoma of the ethmoids in an infant. ( 26265837 )
2015
37
Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT. ( 26053714 )
2015
38
Giant cell variant of malignant fibrous histiocytoma of male breast: A rare case report. ( 26458656 )
2015
39
Epithelioid sarcoma resembling benign fibrous histiocytoma. ( 25750961 )
2015
40
Clinicopathological features of angiomatoid fibrous histiocytoma: a series of 21 cases with variant morphology. ( 25755773 )
2015
41
A rare case of carcinosarcoma of breast: Coexistence of mucinous carcinoma and malignant fibrous histiocytoma. ( 26881584 )
2015
42
Primary intracranial angiomatoid fibrous histiocytoma presenting with anaemia and migraine-like headaches and aura as early clinical features. ( 25900984 )
2015
43
Benign fibrous histiocytoma of the thoracic spine as the cause of pyrexia of unknown origin identified by positron emission tomography/computed tomography. ( 25771758 )
2015
44
En bloc spondylectomy for primary malignant fibrous histiocytoma of the thoracic spine with aortic involvement: case report. ( 25658464 )
2015
45
Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase. ( 26045796 )
2015
46
A Case of Cellular Fibrous Histiocytoma on the Right Elbow with Repeated Relapse within a Short Period. ( 25759652 )
2015
47
Deep benign fibrous histiocytoma in the oral cavity: a case report. ( 26568930 )
2015
48
Characterization of metastatic angiomatoid fibrous histiocytoma. ( 25757019 )
2015
49
Primary pulmonary malignant fibrous histiocytoma. ( 25838959 )
2015
50
Intracranial benign fibrous histiocytoma mimicking parasagittal meningioma: report of two cases and review of literature. ( 26617915 )
2015

Variations for Fibrous Histiocytoma

Expression for Fibrous Histiocytoma

Search GEO for disease gene expression data for Fibrous Histiocytoma.

Pathways for Fibrous Histiocytoma

Pathways related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.33 ATF1 CREB1 MYOD1
2 10.99 ACTC1 DES VIM
3 10.54 ATF1 CREB1
4 10.34 ATF1 CREB1 MITF

GO Terms for Fibrous Histiocytoma

Biological processes related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 intermediate filament organization GO:0045109 8.96 DES VIM
2 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding GO:0003705 9.13 ATF1 CREB1 MYOD1
2 identical protein binding GO:0042802 9.1 CREB1 DES EWSR1 FUS S100B VIM

Sources for Fibrous Histiocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....